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Background: A compelling ethical rationale supports patient engagement in healthcare research. It is also assumed
that patient engagement will lead to research findings that are more pertinent to patients’ concerns and dilemmas.
However; it is unclear how to best conduct this process. In this systematic review we aimed to answer 4 key
questions: what are the best ways to identify patient representatives? How to engage them in designing and
conducting research? What are the observed benefits of patient engagement? What are the harms and barriers of
patient engagement?
Methods: We searched MEDLINE, EMBASE, PsycInfo, Cochrane, EBSCO, CINAHL, SCOPUS, Web of Science, Business
Search Premier, Academic Search Premier and Google Scholar. Included studies were published in English, of any
size or design that described engaging patients or their surrogates in research design. We conducted an
environmental scan of the grey literature and consulted with experts and patients. Data were analyzed using a
non-quantitative, meta-narrative approach.
Results: We included 142 studies that described a spectrum of engagement. In general, engagement was feasible
in most settings and most commonly done in the beginning of research (agenda setting and protocol
development) and less commonly during the execution and translation of research. We found no comparative
analytic studies to recommend a particular method. Patient engagement increased study enrollment rates and
aided researchers in securing funding, designing study protocols and choosing relevant outcomes. The most
commonly cited challenges were related to logistics (extra time and funding needed for engagement) and to an
overarching worry of a tokenistic engagement.
Conclusions: Patient engagement in healthcare research is likely feasible in many settings. However, this
engagement comes at a cost and can become tokenistic. Research dedicated to identifying the best methods
to achieve engagement is lacking and clearly needed.
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The role of patient in research ranges from a passive one
(patient is a data point) to an active one (patient is a
researcher). The active participation in research (or
patient engagement in research) can potentially lead to
improvement in the credibility of results (higher rates of* Correspondence: murad.mohammad@mayo.edu
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unless otherwise stated.enrollment and retention) and in their direct applicability
to patients (by asking pertinent questions about patient-
important outcomes). Also, there is an overarching ethical
mandate for patient participation in research as a mani-
festation of the “democratization” of the research process
[1-3]. Patient engagement in the planning and execution
of research could also improve its translation into clinical
practice [4]. In all, there is growing consensus about the
crucial role of patient involvement in research, which may
improve the value of healthcare research.al Ltd. This is an Open Access article distributed under the terms of the Creative
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in social and health care policy has been well recognized
since 1996. The British National Institute of Health
recognized that individual and community stakeholders
determine important aspects of health care services and
research, and the project INVOLVE was established to
achieve this engagement [5,6]. In the United States, the
Patient Centered Outcomes Research Institute (PCORI)
was established in 2010 and placed great importance on
the engagement of patients and other stakeholders in
the research process [7].
Previous systematic reviews have described various
aspects of the engagement process [8,9]. However, it
remains unclear who to engage or when, or how to per-
form this task [8-10]. Therefore, PCORI commissioned a
systematic review that aims at synthesizing the existing
evidence about patient engagement in research with the
goal of helping researchers in designing and conducting
meaningful patient engagement in healthcare research.
In this systematic review we aimed to answer 4 key
questions: what are the best ways to identify patient
representatives? How to engage them in designing and
conducting research? What are the observed benefits of
patient engagement? What are the harms and barriers of
patient engagement?
Methods
This systematic review is conducted based on a priori
established protocol (Additional file 1) and is reported
according to the PRISMA statement [11]. The PRISMA
checklist is available in Additional file 2.
Eligibility criteria
We included all original studies of any design, size,
or patient population published in the English lan-
guage in which patients or their surrogates provided
feedback, had input, or took part in the design, con-
duct and dissemination of research. Systematic re-
views were also included to supplement the findings
from original studies. Other non-original studies (non-sys-
tematic literature reviews, comments, opinions, letters
and editorials etc.) were excluded. In general, we sought
studies in which patients were actively engaged in de-
signing research. Participation in surveys was only
considered to be research engagement when the main
purpose of the survey was to obtain patients’ values
and preferences that relate to research prioritization
or research design.
Patient advisory group
The protocol of this systematic review was developed
after consultation with patients from the Patient Advisory
Council [12]. This is a group of volunteer patients from
Rochester, Minnesota who have contributed to the designof multiple studies over the last 10 years. The group
helped in developing the questions and outcomes of the
review and advised on terminology. They also reviewed
the results and provided feedback on the presentation of
findings, usefulness and applicability.
Search
Electronic search
An expert librarian (PJE) collaborated with a methodologist
(MHM) to develop the search strategy. We searched bio-
medical electronic databases [PubMed/Ovid MEDLINE,
Ovid EMBASE, Ovid PsycInfo, Ovid Cochrane, EBSCO
CINAHL, SCOPUS, Web of Science (multidisciplinary sci-
entific content), Business Search Premier, Academic Search
Premier and Google Scholar (communications, marketing,
public opinion, and business literature that incorporate
non-healthcare resources)] from their inception through
November 2011 (Additional file 1).
To identify additional candidate studies we reviewed
reference lists from eligible studies and conducted add-
itional MEDLINE searches using the PubMed “related
articles” feature for eligible studies. We used SciSearch
for publications that cited eligible studies to supplement
the database search.
Environmental scan
We complemented the database search with an environ-
mental scan and a manual search. The environmental
scan includes searching the Internet using various search
engines for recent and ongoing activities, initiatives,
white papers and websites to identify key players and
trends in the field. It helps provide content from grey
(unpublished) literature and from fields other than medi-
cine. We also searched the scientific search engines Scirus
and Sciverse, which contain scientific journal content, sci-
entists’ homepages, courseware, pre-print server material,
patents, and institutional repository and website infor-
mation. In addition, we contacted experts in the field to
identify other relevant documents (e.g., dissertations,
scientific reports). The environmental scan, as expected,
identified some of the published literature already in-
cluded in the systematic review; overlapping references
were excluded.
Study selection
We collated initial references in citation files (using
Endnote software), removed duplicates, and screened
titles and abstracts against eligibility criteria using Distil-
lerSR software (Evidence Partners Incorporated, Ottawa,
Canada). Studies were reviewed in duplicate until almost
perfect agreement (Kappa > 0.80) [13] was achieved, after
reviewing 200 potentially includible references. Disagree-
ments in the initial screening were automatically included.
Potentially eligible studies were then reviewed in full text
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screening were reconciled by discussion, consensus, or ar-
bitration by study principal investigator (MHM). We ex-
clusively used electronic file formats (Portable Document
Format/PDF), in reference management software to
reduce costs and paper use.
Data extraction
Data were extracted from included studies using a stan-
dardized form developed based on the protocol. We tested
this form using a small sample (n = 10) of randomly selec-
ted studies, from which all reviewers extracted data. The
first author (JPD) evaluated each extraction form and
compared the extracted data between reviewers and dis-
cussed discrepancies with them.
Data extracted from each study included: study de-
scription (e.g., demographics of participants and research
setting), methods used to select patients (defined as a
patient, surrogate, caregiver, community member, or
other stakeholder informing research), measures set in
place to enhance the validity or completeness of identify-
ing patients (e.g., selecting methods –convenience, ran-
dom, volunteer, training level for the task), measures of
validity or accuracy of the information or input given by
participants (the patient’s voice, e.g., validation of the
patient reported outcome measurement, congruence of
patient’s voice with other stakeholders), description of
methods used to implement/incorporate the patient’s
voice in research, and any reported outcomes of patient
engagement. We also captured authors’ recommen-
dations about the methods to be used for eliciting the
patient’s voice and facilitating patient engagement.Figure 1 Analytical framework.Analysis
The nature of the question of this systematic review
along with the lack of standard approach across existing
studies prevented a quantitative meta-analysis. Instead,
data extracted from the included studies were analyzed
using a meta-narrative approach [14]. This approach was
developed as a pragmatic solution to study topics that
have been differently conceptualized and studied by dif-
ferent groups of researchers [15]. The approach starts by
a standard systematic review with explicit inclusion and
exclusion criteria. Analysis follows a framework that
defines the key questions. The included studies are eval-
uated until saturation for discrete themes and trends
that can be mapped to outcomes. Differences in studies
settings and characteristics can be used to explain differ-
ences in results (heterogeneity) [16].
The analytic framework of this systematic review
is depicted in Figure 1 showing the 4 key questions of
interest. Following this approach, patient engagement
experiences reported in the literature were classified into
categories based on how patients were selected and en-
gaged. Then, we attempted to map each category to an en-
gagement outcome corresponding to the 4 key questions
to allow inference.
We also categorized the research engagement from
each study into three different research phases proposed
for patient engagement [17]:
1) Preparatory phase (agenda setting, prioritization of
research topics and funding).
2) Execution phase (study design & procedures, study
recruitment, data collection, and data analysis).
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and evaluation).
Results are presented following the sequence of the 4
key questions as depicted in the framework (Figure 1)
with illustrative examples.
Results
Search and selection results
Overall we identified 5,562 possibly relevant citations, of
which 142 met the eligibility criteria and were included.
Studies reported a spectrum of engagement. Studies
described patient engagement in research preparation
phase (35), execution phase (90) and translation phase
(52). Some studies contributed to our understanding of
more than one phase.
In terms of the 4 key questions of this review, we
found 121 studies that contributed to our understanding
of the first question regarding patient selection; 45 stud-
ies that contributed to our understanding of the second
question regarding engagement methods; 43 studies that
reported on the third question regarding engagement
outcomes; and 36 studies that reported on the fourth
question regarding barriers and challenges of engage-
ment. Many studies contributed to our understanding of
more than one of the 4 key questions.
The study selection process is described in Figure 2.
The studies included 8 systematic reviews, 7 randomizedFigure 2 Study selection process.trials and 24 observational studies; the remaining majority
(103) consisted of qualitative studies. Additional file 3:
Tables S1 and S2 describe the characteristics of the
systematic reviews and original studies. Due to the
qualitative component of our research question and
the heterogeneity of studies design, the methodo-
logical quality of the included studies was evaluated
using selected items from the list proposed by the
Critical Appraisal Skills Programme (CASP) [18,19].
The studies overall had a few limitations particularly
in the areas of patient selection and data synthesis
(Additional file 3: Table S3). Additional file 3: Table S4
shows the list of initiatives and patient organizations
engaging patients in research identified by the environ-
mental scan.
Overview of existing systematic reviews
The literature search identified 8 relevant systematic
reviews that addressed various aspects of patient enga-
gement and spanned across the 4 key questions. A
Cochrane systematic review by Nilsen et al. [8] reported
that engaging patients in the research process may lead
to an output (report) that is more readable and under-
standable by other patients. The authors concluded that
there are insufficient data to evaluate the impact of
patient engagement. Nevertheless, they found that the
engagement was feasible in most of their included ran-
domized controlled trials.
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the impact of patient and public involvement in the UK
National Health Service programs. The review sum-
marized 42 studies and concluded that there is little
evidence of any economic analysis of the costs involved,
poor quality of reporting, minimal theoretical or concep-
tual underpinning, lack of measurement and evaluation;
and overall weak evidence base to support patient and
public engagement.
Brett et al. [1] examined the conceptualization,
measurement, impact and outcomes of patient and
public involvement in health and social care research.
They concluded that there is an emerging and im-
portant evidence of the impact of patient engagement
on health care research but with relatively little
conceptualization and theoretical development in the
field. They also described poor quality of reporting
as a one of the most important barriers restricting
our understanding of the impact of patient engage-
ment in research.
Boote et al. [20] reviewed published case examples
of public involvement in primary research design and
reported that group meetings were the most common
method used to engage the public and that most pa-
tient contributions were in the areas of review of
consent procedures and patient information sheets, out-
come suggestion, and recommendations on participants
recruitment.
Three systematic reviews by Legare et al., Oliver et al.,
and Stewart et al., summarized collectively over 250
studies in which patient engagement was conducted
[10,21,22]. The three reviews reported similar key find-
ings and focused on describing topics and stages of re-
search most amenable to engagement and common
methods of engagements (e.g., meetings, workshops and
focus groups) that should be tailored to the topic of re-
search at hand. These reviews also highlighted chal-
lenges and barriers to engagement [10,21,22].
Lastly, Hussain-Gambles [23] focused on engaging
South Asian patients in designing clinical trials and
reported on the factors that motivate patients to partici-
pate as well as deterrents. The review highlighted that
there are more similarities than differences in attitudes
towards clinical trials between the South Asian and the
general population. The main findings and conclusions
of the 8 systematic reviews are reported in Additional
file 2: Table S3.
Key questions
Question 1. What are the best methods to identify patients
for engagement?
In general, most of the studies described convenience sam-
pling as the method to identify patients (or representatives/
surrogates) for engagement in research. Therefore, patientsattending clinics or other patient care facilities were
approached and asked to participate. Patients also
volunteered in a response to advertisements or Internet
postings. Very few studies randomly selected patient
representatives. For example, researchers in the Neth-
erland randomly selected patients with asthma and
chronic obstructive pulmonary disease from the entire
pool of the Netherlands Asthma Foundation and engaged
these patients in consultation to define their health re-
search priorities [24]. This engagement resulted in add-
itional prioritization of other research topics that were
not covered by current Dutch research programs. Re-
searchers in Canada randomly selected from patients at-
tending outpatient cancer therapy to evaluate their
attitudes, motivations and barriers to participation in
clinical trials [25]. Murad et al. asked a random sample of
patients with diabetes about their preferences for future
trials in diabetes in terms of design (pragmatic vs.
explanatory trial design) and outcomes (surrogate vs. hard
endpoints) [26].
We found no comparative analytic studies to provide
evidence supporting a particular method to identify or se-
lect patients for engagement in research.
Question 2. What are the best methods to engage patients?
Studies described a variety of methods that were used to
engage patients, the most common of which were focus
groups, interviews, surveys and the most active form of
engagement which is serving on a study board or advis-
ory council and attending regular meetings with re-
searchers (as in active participatory research studies and
community based participatory research). For example,
Swartz et al. conducted a randomized controlled trial to
test the effectiveness of a pollutant and allergen control
strategy on the symptoms of childhood asthma [27]. In
the early stages of the study, researchers engaged several
stakeholders (2 school principals, a pastor, a nun, 2 com-
munity association presidents, a social worker, a parent
of a child with asthma and a health care worker who
had previously served in the same community). The en-
gaged persons took the role of an advisory board and a
partner in research. They helped develop study protocol,
recruitment procedures and selected outcomes. They
also educated study personnel about the community
and attended presentations and meetings to obtain
necessary approvals for the study. They subsequently
even helped with execution of study intervention
(measured pollutant levels in demolition sites). Crowe
et al. described the engagement of Hispanic farm wor-
kers and their families in Yakima Valley, Washington, in
every stage of a study including study concept and
design, data collection, data analysis and interpret-
ation, conclusions, and dissemination of results [28].
Thirteen community members and stakeholders met
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ing input and making decisions about research exe-
cution. The engaged persons also presented alongside
researchers to the larger community during Town Hall
meetings.
We found no comparative analytic studies to provide
evidence supporting a particular method of engagement.
The different methods used for engagement are depicted
in Figure 3 and are stratified according to research
phase.
Question 3. What are the observed benefits of patient
engagement?
Several studies reported that engaging patients in
research improves patient enrollment and decrease
attrition [10,27,29-31]. For instance, Edwards et al. [30]
conducted a randomized controlled trial of osteopathy
in children with cerebral palsy compared to a control
group that only received standard therapy. They demon-
strated that engaging parents in study design led to
higher enrollment and retention rates. Likewise, Swartz
et al. [27] conducted a randomized controlled trial in
inner-city children with asthma comparing environmen-
tal control education, allergen-proof encasements, pest
extermination, and an air filter to a control group that
only received standard therapy. The used a community
based participatory research approach, which achieved
a high enrollment and retention rates, 86% and 70%
respectively. They also reported that engagement helped
in dissemination to the extent that their reporting was
more meaningful and understandable for participants
and the community.Figure 3 Methods and phases of engagement.Question 4. What are the harms and barriers of patient
engagement?
While most studies reported mainly positive effects of
engagement, [1] a smaller number described potential
harms or adverse effects of engaging patients. These
harms mainly related to patient frustration with the
lengthy process that involved training, transportation,
attendance, etc. [31,32]. In terms of barriers and chal-
lenges, studies cited logistics such as extra time needed
to complete research, time constraints of patients and
researchers, and incremental funding needed for patient
engagement. Another common concern and an over-
arching worry of researchers and patients was that pa-
tient engagement may become tokenistic [33,34] (a false
appearance of inclusiveness), resulting in a devaluated
patients’ input. Another potential challenge described
was “scope creep”; a theoretical concern that engaging
patients in the research may include irrelevant com-
munity concerns and issues, which would make the re-
search unfeasible [27,35].
Of the few studies that described potential solutions,
the most commonly described were spending adequate
time to build reciprocal relationships [17] (between pa-
tients and researcher), fostering mutual respect and devel-
oping clear expectations that are explicitly described and
documented in study protocols. We found no comparative
studies to provide supportive evidence for question 4.
Discussion
This meta-narrative systematic review identified numer-
ous heterogeneous studies in which patients or their
surrogates (other patients) were successfully engaged in
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most of the published cases we found, but faced several
challenges and barriers. Most studies claimed some ben-
efits of this process; however, there were no comparative
data to suggest best practices.
Strengths and limitations
Heterogeneity of study populations, methods, and out-
comes constitute limitations of this synthesis. Publica-
tion and reporting biases might have impacted the
conclusions of this report and their impact cannot be
estimated. Our search may have missed studies in which
patient engagement was performed due to the lack of
uniform reporting or indexing methods of engagement.
Evaluating the quality of patient engagement is chal-
lenging due to unavailability of validated scales and the
limited data reported in the studies. We did not find the
standard tools for assessing the methodological quality
of the studies particularly useful because such assess-
ment actually relates to the outcomes of the study and
not to the outcome of patient engagement. Such assess-
ment can be misleading as it is quite possible to have a
study with low risk of bias for its primary and secondary
outcomes that performed tokenistic or ineffective patient
engagement.
Our results are consistent with other systematic
reviews in the field [1,8,9]. The current review updates
the evidence base to date and provides a contemporary
look at patient engagement. Developed with active par-
ticipation from patients, researchers, and the PCORI
staff (as an external experts’ advisory group that did not
participate in conducting this SR), this systematic review
takes priority in establishing the baseline starting point
from which we need to advance the science of patient
engagement in research. This review utilized a compre-
hensive and sensitive search strategy that spanned across
multiple databases and was augmented by an environ-
mental scan of non-peer-reviewed relevant sources to
further capture related studies, web sites, and interest
groups. Our application of an a priori protocol for selec-
ting and appraising evidence reduces selection bias. The
thematic analysis of this review sought to ensure pre-
senting the evidence without over-interpreting its signals
and silences, a key concern in this area.
Practical implications
At the present time we are unable to recommend best
practices on the basis of comparative evidence. However,
many methods are described in the literature with repor-
ted success. In terms of identifying patients for engage-
ment, random sampling is the least biased way although
considering that the number of patients chosen for
engagement is very small, random sampling can fail.
This approach is also challenging in rare diseases. Mostof the included studies used volunteers which is a more
practical method despite the potential for having a sam-
ple of patients that are not truly representative of the
targeted population. Volunteers may be more educated
and motivated and engage more effectively, yet they may
have personal agendas. At the present time, we suggest
that researchers choose their method of selection based
on the availability of subjects and the research topic
at hand.
Engaging patients in all research phases (preparatory,
execution and translation) seems feasible in most cases.
This was even demonstrated in populations and commu-
nities with high prevalence of social inequities (intellec-
tual disparities, poverty, unemployment and illiteracy)
traditionally considered difficult to reach [36-40]. The
engagement process may improve the credibility of
results and their applicability to the target population
and may have an empowering effect on participants.
Potential risks (harms and costs) for engaged patients
should be balanced against the broad range of articu-
lated potential benefits.
Future research in this field is greatly needed to dem-
onstrate the value of patient engagement to researchers
and funders. For example, patient engagement when
conducting systematic reviews has been recommended
by the Agency for Healthcare Research and Quality
Evidence-based Practice Centers, the Institute of Medi-
cine, the Cochrane Collaboration, and others [41]. Yet,
there is no guidance on how to perform this engage-
ment. A possible study in this field can randomize sys-
tematic reviewers to test three approaches, one without
engaging patients, one with engaging patients with the
condition being studied, and one with engaging patients
with any condition (general patients). Qualitative studies
can be embedded in most trials to evaluate different en-
gagement strategies or engagement in different phases of
the trials. Clinical practice guidelines are mostly done
without patient engagement;[42] however this engage-
ment is described by many as paramount and essential
[43,44]. The impact of patient representation on guide-
line panels cane be studied using qualitative research
methods to determine if their presence was tokenistic or
meaningful. Lastly, we recommend that bibliographic
databases use indexing terms that identify active patient
engagement in research to facilitate future research in
this field.Conclusions
Patient engagement in healthcare research is likely feas-
ible in many settings. However, this engagement comes
at a cost and can become tokenistic. Research dedicated
to identifying the best methods to achieve engagement is
lacking and clearly needed.
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